Market Currents
BioCryst (BCRX -4.7%) trades lower today following the announcement that its investigational new...
-
Tuesday, November 27, 2012, 2:46 PM ETBioCryst (BCRX -4.7%) trades lower today following the announcement that its investigational new drug BCX4161 has been put on a clinical hold due to manufacturing issues. JMP Securities cut the shares to Market Perform on the news.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
